B HALL STRATEGIES, LLC - 2025 second_quarter

Lobbying Activities

Health IssuesView all

Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products.

Budget/AppropriationsView all

Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products.

Medical/Disease Research/Clinical LabsView all

Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products.

Lobbyists (1)

mr JAMES BRYANT HALL ii

Staff Director, Sen. Veterans Affairs Committee (2003-2004); Legislative Director, Sen. Bob Graham (1999-2003)

New

Foreign Entities

JAZZ PHARMACEUTICALS PLC

IE0Ownership: 100%

Affiliated Organizations

GREENWICH BIOSCIENCES, INC.

Carlsbad, CA, US

2025 second_quarter Filing

Lobbying Activities

Lobbyists (1)

Foreign Entities

Affiliated Organizations